What is the dosage of Stelara?

Stelara is available in 4 dosages, including 5 mg/ml Injection 26 ml, 90 mg/ml Injection 0.5 ml, 90 mg/ml Prefilled Syringe 0.5 ml and 90 mg/ml Prefilled Syringe 1 ml

What does Stelara treat?

Stelara treats Crohn Disease and Psoriatic Arthritis

What is Stelara made of?

Stelara contains ustekinumab which is a Interleukin-12 Antagonist

How is Stelara administered?

Stelara is administered as a Injectable

What is Stelara mechanism of action?

Stelara mechanism of action is Interleukin-12 Antagonists or Interleukin-23 Antagonists

Dosage & Administration Drug label Prior authorization Financial assistance

Patient education

Stelara

(ustekinumab)

0.5 ML ustekinumab 90 MG/ML Injection [Stelara]0.5 ML ustekinumab 90 MG/ML Prefilled Syringe [Stelara]

View 2 more

NO BLACK BOX WARNING

Dosage & administration

Psoriasis Adult Subcutaneous Recommended Dosage :

Weight Range (kilograms)	Dosage Regimen
less than or equal to 100 kg	45 mg administered subcutaneously initially and 4 weeks later, followed by 45 mg administered subcutaneously every 12 weeks
greater than 100 kg	90 mg administered subcutaneously initially and 4 weeks later, followed by 90 mg administered subcutaneously every 12 weeks

Psoriasis Pediatric Patients (6 to 17 years old) Subcutaneous Recommended Dosage :

Weight-based dosing is recommended at the initial dose, 4 weeks later, then every 12 weeks thereafter.

Weight Range (kilograms)	Dose
less than 60 kg	0.75 mg/kg
60 kg to 100 kg	45 mg
greater than 100 kg	90 mg

Psoriatic Arthritis Adult Subcutaneous Recommended Dosage :

* The recommended dosage is 45 mg administered subcutaneously initially and 4 weeks later, followed by 45 mg administered subcutaneously every 12 weeks.
* For patients with co-existent moderate-to-severe plaque psoriasis weighing greater than 100 kg, the recommended dosage is 90 mg administered subcutaneously initially and 4 weeks later, followed by 90 mg administered subcutaneously every 12 weeks.

Psoriatic Arthritis Pediatric (6 to 17 years old) Subcutaneous Recommended Dosage : Weight-based dosing is recommended at the initial dose, 4 weeks later, then every 12 weeks thereafter.

Weight Range (kilograms)	Dosage Regimen
less than 60 kg	0.75 mg/kg
60 kg or more	45 mg
greater than 100 kg with co-existent moderate-to-severe plaque psoriasis	90 mg

Crohn's Disease and Ulcerative Colitis Initial Adult Intravenous Recommended Dosage :

A single intravenous infusion using weight-based dosing:

Weight Range (kilograms)	Recommended Dosage
up to 55 kg	260 mg (2 vials)
greater than 55 kg to 85 kg	390 mg (3 vials)
greater than 85 kg	520 mg (4 vials)

Crohn's Disease and Ulcerative Colitis Maintenance Adult Subcutaneous Recommended Dosage :

A subcutaneous 90 mg dose 8 weeks after the initial intravenous dose, then every 8 weeks thereafter.

Stelara prescribing information

Have more Stelara questions?

Submit MSL Request

Learn More

Need to report a Stelara issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Stelara Prior authorization resources

Complete Letter of Medical Necessity

Coverage Authorization Request

NOT PROVIDED BY BRANDComplete Coverage Authorization appeals

Gastroenterology Enrollment Form

Coverage Authorization Appeal

Dermatology & Rheumatology Enrollment Form

Learn More

Benefits investigation

Get Benefits Investigation Support

Gastroenterology Enrollment Form

Dermatology & Rheumatology Enrollment Form

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Stelara Financial assistance options

Co-pay savings program

commercial only

Enroll in patient savings program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Janssen Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement